The Technical University of Munich (TUM) is one of Germany’s top universities and is characterized by a unique profile with its core domains natural sciences, engineering, life sciences, and medicine. The institutional strategy is focused on strengthening the excellence of disciplinary core competences in research, teaching and learning, but is also targeted towards the promotion of groundbreaking, interdisciplinary research. TUM is committed toward the major challenges facing society in the 21st century in areas such as energy, climate, and environment, natural resources, health and nutrition, communication and information, mobility, and infrastructure. Besides research and teaching, TUM inspires and pro-actively empowers its students, academics, and alumni to think and act entrepreneurially. It initiates growth oriented start-ups and assists its entrepreneurs in building new companies (TUM Entrepreneurship).
TUM participates with the Chair for Biological Imaging (CBI, Chair: Prof. Ntziachristos) at TranslaTUM, a multidisciplinary research center in the Medical Faculty and University Hospital merging strong medical engineering and photonics expertise with clinical access. CBI closely synergizes with the Institute for Biological and Medical Imaging (IBMI) at the Helmholtz Center in Munich, solidifying world-leading research expertise and infrastructure relating to INNODERM, which in combination with exceptional SMEs and clinical partners, builds the foundation for successful completion of the project. Moreover, Prof. Ntziachristos has an extensively proven and highly successful track record on managing innovation with several products driven by his research on the market today: FMT by Perkin Elmer, MSOT by iThera Medical GmbH and T3 Fluorescence Imaging by SurgVision B.V. (now acquired by Bracco SpA.
TUM enters INNODERM with a dual capacity: as Coordinator and lead engineering entity.